ATE239047T1 - Polymere antitumormittel - Google Patents

Polymere antitumormittel

Info

Publication number
ATE239047T1
ATE239047T1 AT95307637T AT95307637T ATE239047T1 AT E239047 T1 ATE239047 T1 AT E239047T1 AT 95307637 T AT95307637 T AT 95307637T AT 95307637 T AT95307637 T AT 95307637T AT E239047 T1 ATE239047 T1 AT E239047T1
Authority
AT
Austria
Prior art keywords
antitumor agents
polymeric antitumor
polymeric
agents
mammal
Prior art date
Application number
AT95307637T
Other languages
English (en)
Inventor
Hwei-Ru Tsou
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE239047T1 publication Critical patent/ATE239047T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/028—Polyamidoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0273—Polyamines containing heterocyclic moieties in the main chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AT95307637T 1994-11-01 1995-10-26 Polymere antitumormittel ATE239047T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33266194A 1994-11-01 1994-11-01
US08/521,505 US5609867A (en) 1994-11-01 1995-08-29 Polymeric antitumor agents

Publications (1)

Publication Number Publication Date
ATE239047T1 true ATE239047T1 (de) 2003-05-15

Family

ID=26988319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95307637T ATE239047T1 (de) 1994-11-01 1995-10-26 Polymere antitumormittel

Country Status (11)

Country Link
US (1) US5609867A (de)
EP (1) EP0710689B1 (de)
JP (1) JPH08253420A (de)
AT (1) ATE239047T1 (de)
AU (1) AU690740B2 (de)
CA (1) CA2161603A1 (de)
DE (1) DE69530552T2 (de)
DK (1) DK0710689T3 (de)
ES (1) ES2197183T3 (de)
PT (1) PT710689E (de)
TW (1) TW383318B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69708461T2 (de) * 1996-02-15 2002-06-27 Marc W. Mittelman Bioresponsive pharmakologisch aktive polymere und daraus hergestellte gegenstände
WO2015013581A1 (en) 2013-07-26 2015-01-29 Update Pharma Inc. Combinatorial methods to improve the therapeutic benefit of bisantrene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714993A (en) 1970-11-23 1973-02-06 Hughes Tool Co Valving tube subassembly for percussion bit
US4197249A (en) 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4526788A (en) * 1983-03-18 1985-07-02 American Cyanamid Company Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones
US4520162A (en) * 1983-09-24 1985-05-28 Director-General Of The Agency Of Industrial Science & Technology Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof
GB8413464D0 (en) 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
AU605512B2 (en) * 1986-10-07 1991-01-17 Boehringer Mannheim Italia S.P.A. Pharmaceutical compositions having antineoplastic activity
US5378456A (en) 1993-03-25 1995-01-03 American Cyanamid Company Antitumor mitoxantrone polymeric compositions

Also Published As

Publication number Publication date
TW383318B (en) 2000-03-01
DE69530552D1 (de) 2003-06-05
DK0710689T3 (da) 2003-08-04
EP0710689A2 (de) 1996-05-08
CA2161603A1 (en) 1996-05-02
JPH08253420A (ja) 1996-10-01
AU3454795A (en) 1996-05-09
EP0710689B1 (de) 2003-05-02
DE69530552T2 (de) 2003-11-20
PT710689E (pt) 2003-08-29
AU690740B2 (en) 1998-04-30
ES2197183T3 (es) 2004-01-01
US5609867A (en) 1997-03-11
EP0710689A3 (de) 1996-11-20

Similar Documents

Publication Publication Date Title
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
DE3865817D1 (de)
NZ225339A (en) Compounds having biocidal properties and pharmaceutical compositions
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
EP1760067A3 (de) Verbindungen mit geschützten Hydroxylgruppen
BG106390A (en) Novel spiro compounds
IL143747A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
PT1130963E (pt) Combinacoes de substancias activas fungicidas
IN170909B (de)
PL371464A1 (en) 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and processes for making them
ATE216366T1 (de) 2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression
DE60013994D1 (de) 1,2-Disubstituierte 1,4-Dihydro-4-oxochinolin-Verbindungen
DE69124844D1 (de) Radicicol-Derivate, ihre Herstellung und ihre Antitumorwirkung
ATE239047T1 (de) Polymere antitumormittel
DK0688212T3 (da) C9-taxanderivater og farmaceutiske præparater indeholdende disse
EP0237829A3 (en) Tetrahydro-3,4-furandiamine-n-n'-platinum complexes
EP0297594A3 (de) 3',4'-Di-N-substituierte Epipodophyllotoxin-Glucosid-Derivate
TR24789A (tr) Tiodikarb ve bir fenilpirazol ihtiva eden artropodisidal terkip
ID27733A (id) Metoksiminofenilasetamida
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
IL141655A0 (en) A process for the preparation of midodrine
IL161920A0 (en) Photochromic oxazine compounds and methods for their manufacture
ES8801647A1 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0710689

Country of ref document: EP

REN Ceased due to non-payment of the annual fee